These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11144552)

  • 1. DNA microarrays and combinatorial chemical libraries: tools for the drug discovery pipeline.
    Barry CE; Wilson M; Lee R; Schoolnik GK
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S189-93. PubMed ID: 11144552
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of conformationally constrained analogues of the antitubercular agent ethambutol.
    Faugeroux V; Génisson Y; Salma Y; Constant P; Baltas M
    Bioorg Med Chem; 2007 Sep; 15(17):5866-76. PubMed ID: 17566744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of novel ethambutol analogues.
    Yendapally R; Lee RE
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1607-11. PubMed ID: 18242089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM; Zalutskaia OM; Roth A; Mauch H; Nikolenko EN
    Probl Tuberk; 2001; (5):43-5. PubMed ID: 11588962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis.
    Gryadunov D; Mikhailovich V; Lapa S; Roudinskii N; Donnikov M; Pan'kov S; Markova O; Kuz'min A; Chernousova L; Skotnikova O; Moroz A; Zasedatelev A; Mirzabekov A
    Clin Microbiol Infect; 2005 Jul; 11(7):531-9. PubMed ID: 15966970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
    Chakraborty S; Rhee KY
    Cold Spring Harb Perspect Med; 2015 Apr; 5(8):a021147. PubMed ID: 25877396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG; Lötter AP
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].
    Afanas'ev MV; Ikriannikova LN; Il'ina EN; Smirnova TG; Larionova EE; Kuz'min AV; Chernousova LN; Kamaev EIu; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
    Probl Tuberk Bolezn Legk; 2007; (7):37-42. PubMed ID: 17722291
    [No Abstract]   [Full Text] [Related]  

  • 12. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress on mechanism of ethambutol resistance in Mycobacterium Tuberculosis.
    Wang T; Jiao WW; Shen AD
    Yi Chuan; 2016 Oct; 38(10):910-917. PubMed ID: 27806932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
    Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array.
    Moure R; Español M; Tudó G; Vicente E; Coll P; Gonzalez-Martin J; Mick V; Salvadó M; Alcaide F
    J Antimicrob Chemother; 2014 Apr; 69(4):947-54. PubMed ID: 24216765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
    Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
    Aragón LM; Navarro F; Heiser V; Garrigó M; Español M; Coll P
    J Antimicrob Chemother; 2006 May; 57(5):825-31. PubMed ID: 16547071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.